Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Sage_Therapeutics
|
| gptkbp:activities |
antagonist of NMDA receptor
|
| gptkbp:developed_by |
gptkb:Sage_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
SAGE-689
|
| gptkbp:ingredients |
C18 H20 Cl N3 O2 S
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:manager |
oral
|
| gptkbp:research_areas |
treatment of depression
|
| gptkbp:targets |
NMDA receptor
|
| gptkbp:type_of |
1234567-89-0
|
| gptkbp:weight |
367.89 g/mol
|